Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 11, 2010

View Archived Issues

Ad28-based adenovirus vector is strongly immunogenic

Daiichi Sankyo claims new Mdm2-p53 interaction inhibitors

German scientists disclose new inhibitors of tau aggregation

Italian researchers describe new antimicrobial agents

New tyrosine-protein kinase inhibitors claimed by sanofi-aventis

New alpha-mannosidase inhibitors identified by Emory University

Mission Pharmacal launches Uribel capsules for symptoms of urinary tract conditions in U.S.

Acrux issues update on female health products

QRxPharma reports encouraging phase II proof-of-concept data on MoxDuo IV

New models predict activity/selectivity of cannabinoid receptor agonists/antagonists

Clomipramine reduces GFAP levels in Alexander's disease model / News in Context

Pfizer describes MR antagonist for diabetic nephropathy

AM-643 is a candidate for topical treatment of skin disorders

Elan and Transition Therapeutics report phase II data on ELND-005 in Alzheimer's disease

FDA grants orphan drug status to CYT-387 for myelofibrosis

Fibrocell Science submits phase II/III Azficel-T trial report to FDA

ILLUMINATE trial supports 24-week telaprevir-based therapy in HCV infection

FDA grants priority review to rifaximin sNDA for non-constipation-predominant IBS

Scancell and Cancer Research Technology sign antibody license agreement

Teva Pharmaceutical acquires ratiopharm

Lentigen receives NIH grant to develop melanoma immunotherapy

Genmab presents phase II ofatumumab data in diffuse large B-cell lymphoma

Shire divests ADHD therapeutic Daytrana to Noven Pharma

NsGene and Biogen Idec sign new agreement for artemin

Advanced Life Sciences and FDA reach SPA agreement for phase III Restanza trial in pneumonia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...